# Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers

> **NCT05120947** · NA · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 18 (actual)

## Conditions studied

- Resectable Head and Neck Squamous Cell Carcinoma

## Interventions

- **RADIATION:** 42 Gy Radiation Therapy
- **RADIATION:** 39 Gy Radiation Therapy
- **RADIATION:** 32.5 Gy Radiation Therapy

## Key facts

- **NCT ID:** NCT05120947
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-11-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05120947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05120947, "Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05120947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*